EE03353B1 - Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid - Google Patents

Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid

Info

Publication number
EE03353B1
EE03353B1 EE9600135A EE9600135A EE03353B1 EE 03353 B1 EE03353 B1 EE 03353B1 EE 9600135 A EE9600135 A EE 9600135A EE 9600135 A EE9600135 A EE 9600135A EE 03353 B1 EE03353 B1 EE 03353B1
Authority
EE
Estonia
Prior art keywords
tetradesoxy
galactonone
glycero
guanidino
acetamido
Prior art date
Application number
EE9600135A
Other languages
English (en)
Estonian (et)
Inventor
Williamson Christopher
James White William
Patel Vipulkumar
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Publication of EE03353B1 publication Critical patent/EE03353B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9600135A 1993-12-17 1994-12-15 Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid EE03353B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325841A GB9325841D0 (en) 1993-12-17 1993-12-17 Chemical compounds
PCT/EP1994/004154 WO1995016680A1 (en) 1993-12-17 1994-12-15 Crystalline n-acetyl neuraminic acid derivatives and processes for their preparation

Publications (1)

Publication Number Publication Date
EE03353B1 true EE03353B1 (et) 2001-02-15

Family

ID=10746778

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600135A EE03353B1 (et) 1993-12-17 1994-12-15 Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid

Country Status (43)

Country Link
US (2) US6294572B1 (cs)
EP (1) EP0734382B1 (cs)
JP (1) JP3317972B2 (cs)
KR (1) KR100403256B1 (cs)
CN (2) CN1132829C (cs)
AP (2) AP9600810A0 (cs)
AT (1) ATE199255T1 (cs)
BG (1) BG63338B1 (cs)
BR (2) BR9408340A (cs)
CA (1) CA2177990C (cs)
CO (1) CO4340619A1 (cs)
CZ (1) CZ289234B6 (cs)
DE (1) DE69426726T2 (cs)
DK (1) DK0734382T3 (cs)
EE (1) EE03353B1 (cs)
EG (1) EG20597A (cs)
ES (1) ES2155517T3 (cs)
FI (1) FI120453B (cs)
GB (1) GB9325841D0 (cs)
GR (1) GR3035681T3 (cs)
HR (1) HRP941001B1 (cs)
HU (1) HU221971B1 (cs)
IL (1) IL112011A (cs)
IS (1) IS4240A (cs)
MA (1) MA23396A1 (cs)
MY (1) MY116221A (cs)
NO (1) NO314759B1 (cs)
NZ (1) NZ277789A (cs)
OA (2) OA10325A (cs)
PE (1) PE31095A1 (cs)
PL (1) PL186384B1 (cs)
PT (1) PT734382E (cs)
RO (1) RO114792B1 (cs)
RU (1) RU2134690C1 (cs)
SA (1) SA94150417B1 (cs)
SG (1) SG46669A1 (cs)
SI (1) SI0734382T1 (cs)
SK (1) SK282972B6 (cs)
SV (1) SV1994000076A (cs)
TW (1) TW452577B (cs)
UA (1) UA46723C2 (cs)
WO (1) WO1995016680A1 (cs)
ZA (1) ZA9410003B (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds
ATE305453T1 (de) * 1995-02-27 2005-10-15 Gilead Sciences Inc Selektive inhibitoren viraler oder bakterieller neuraminidase
US5866601A (en) * 1995-02-27 1999-02-02 Gilead Sciences, Inc. Carbocyclic compounds
US5763483A (en) * 1995-12-29 1998-06-09 Gilead Sciences, Inc. Carbocyclic compounds
PT823428E (pt) * 1996-07-22 2002-04-29 Sankyo Co Derivados do acido neuraminico sua preparacao e sua utilizacao em medicina
US6340702B1 (en) 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US6451766B1 (en) 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
US5859284A (en) 1996-08-23 1999-01-12 Gilead Sciences, Inc. Preparation of carbocyclic compounds
US6518438B2 (en) 1996-08-23 2003-02-11 Gilead Sciences, Inc. Preparation of cyclohexene carboxylate derivatives
US5994377A (en) 1996-10-21 1999-11-30 Gilead Sciences, Inc. Piperidine compounds
US5886213A (en) * 1997-08-22 1999-03-23 Gilead Sciences, Inc. Preparation of carbocyclic compounds
TW480247B (en) * 1997-12-12 2002-03-21 Gilead Sciences Inc Novel compounds useful as neuraminidase inhibitors and pharmaceutical compositions containing same
TWI291462B (en) 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
US20080063722A1 (en) * 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
WO2013089168A1 (ja) * 2011-12-16 2013-06-20 第一三共株式会社 ノイラミン酸誘導体の製造方法
CN109232677B (zh) * 2018-10-18 2021-12-28 中国科学院合肥物质科学研究院 一种使n-乙酰神经氨酸水合物转化为n-乙酰神经氨酸的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU469694A1 (ru) * 1972-12-22 1975-05-05 Московский Ордена Трудового Красного Знамени Институт Тонкой Химической Технологии Им.М.В.Ломоносова Способ получени 2-алкокси-6-алкил (арил)- -дигидропиранов
SK282950B6 (sk) 1990-04-24 2003-01-09 Biota Scientific Management Pty Ltd Deriváty alfa-D-neuramínovej kyseliny, spôsob ich prípravy, ich použitie a farmaceutické prípravky na ich báze
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
US5639786A (en) 1992-12-04 1997-06-17 Biota Scientific Management, Pty., Ltd. Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of α-D-neuraninic acid
GB9325841D0 (en) * 1993-12-17 1994-02-23 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
SK78596A3 (en) 1997-03-05
ES2155517T3 (es) 2001-05-16
ATE199255T1 (de) 2001-03-15
SK282972B6 (sk) 2003-01-09
US20020037865A1 (en) 2002-03-28
HK1014187A1 (en) 1999-09-24
AP9400705A0 (en) 1995-01-31
CN1502621A (zh) 2004-06-09
RU2134690C1 (ru) 1999-08-20
DE69426726D1 (de) 2001-03-29
HRP941001B1 (en) 2001-06-30
CZ169396A3 (en) 1996-11-13
NO962545L (no) 1996-06-14
EP0734382A1 (en) 1996-10-02
FI120453B (fi) 2009-10-30
BR1100548KB1 (pt) 2011-11-01
EP0734382B1 (en) 2001-02-21
CO4340619A1 (es) 1996-07-30
TW452577B (en) 2001-09-01
HU221971B1 (hu) 2003-03-28
PL315055A1 (en) 1996-09-30
BR9408340A (pt) 1997-08-19
AU689185B2 (en) 1998-03-26
HU9601642D0 (en) 1996-08-28
UA46723C2 (uk) 2002-06-17
CA2177990A1 (en) 1995-06-22
HUT74938A (en) 1997-03-28
AP541A (en) 1996-10-01
HRP941001A2 (en) 1997-06-30
NO962545D0 (no) 1996-06-14
CN1142820A (zh) 1997-02-12
ZA9410003B (en) 1995-07-25
RO114792B1 (ro) 1999-07-30
GB9325841D0 (en) 1994-02-23
IL112011A (en) 1998-08-16
CA2177990C (en) 2000-04-25
FI962464L (fi) 1996-06-13
SI0734382T1 (en) 2001-08-31
DK0734382T3 (da) 2001-03-19
AU1314495A (en) 1995-07-03
JPH09506601A (ja) 1997-06-30
FI962464A0 (fi) 1996-06-13
GR3035681T3 (en) 2001-06-29
CN1132829C (zh) 2003-12-31
BG100709A (bg) 1997-01-31
CZ289234B6 (cs) 2001-12-12
MY116221A (en) 2003-12-31
PL186384B1 (pl) 2004-01-30
BG63338B1 (bg) 2001-10-31
SG46669A1 (en) 1998-02-20
OA10325A (en) 1997-10-07
WO1995016680A1 (en) 1995-06-22
AP9600810A0 (en) 1996-07-31
US6294572B1 (en) 2001-09-25
IL112011A0 (en) 1995-03-15
OA11275A (en) 2002-11-20
JP3317972B2 (ja) 2002-08-26
IS4240A (is) 1995-06-18
PT734382E (pt) 2001-06-29
MA23396A1 (fr) 1995-07-01
NZ277789A (en) 1999-04-29
PE31095A1 (es) 1995-10-18
NO314759B1 (no) 2003-05-19
DE69426726T2 (de) 2001-06-21
SV1994000076A (es) 1995-10-26
KR100403256B1 (ko) 2004-04-30
SA94150417B1 (ar) 2005-12-18
EG20597A (en) 1999-09-30

Similar Documents

Publication Publication Date Title
HU9303282D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
EE03474B1 (et) CDCH kristallimodifikatsioon, selle valmistamismeetod ning seda modifikatsiooni sisaldavad farmatseutilised preparaadid
FI935513A7 (fi) Karboksyylihappojohdannaiset, näitä sistältävät lääkeaineet ja menetelmä niiden valmistamiseksi
AU1819088A (en) New amino acid derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
EE03353B1 (et) Kristalne 5-atseetamido-2,3,4,5-tetradesoksü-4-guanidino-D-glütsero-D-galaktonon-2-eenpüranosoonh ape, selle valmistamismeetod ja seda sisaldavad farmatseutilised preparaadid
FI953467A7 (fi) Aminohappojohdannaisia, näitä yhdisteitä sisältävät lääkeaineet ja men etelmä niiden valmistamiseksi
HU9303283D0 (en) Pharmaceutical preparations containing hialuronic acid and/or derivatives and/or fragments
IL100899A0 (en) Beta-amino-alpha-hydroxycarboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL115685A (en) Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
AU7227587A (en) Substituted benzamide derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
HUT71106A (en) Propenoic acid derivatives, pharmaceutical compositions containing them and process for their preparation
FI943902A7 (fi) Kortikosteroidi-17-alkyylikarbonaatti-21-(0)-karboksyylihappo- ja hiilihappoesterit, menetelmä niiden valmistamiseksi ja niitä sisältävät lääkkeet
AU2974189A (en) Pharmaceutical compositions containing lactams, new substituted lactams and processes for the preparation thereof
AU1122688A (en) Substituted 3,4-dihydro-2h-benzopyrans, processes for their preparation, their use and pharmaceutical products based on these compounds
HUT68774A (en) Heterocyclic iminobismethylenebisphosphonic acid derivatives, process for preparing them, and pharmaceutical preparations containing them
FI951961L (fi) Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita
HUT72319A (en) Epoxy-succinic acid derivatives, pharmaceutical compositions containing them and process for their preparation
FI963440A7 (fi) Uudet aminohappojohdannaiset, näiden valmistusmenetelmä ja näitä yhdis teitä sisältävät farmaseuttiset seokset
IL109430A0 (en) Hydroxamic acid derivatives, their preparation and pharmaceutical compositions containing them
FI944751L (fi) Heteroaryylipiperidiinejä, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia
IL99389A0 (en) Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GR3000330T3 (en) N,n-bis-(4-fluorophenyl) carbamoyl acetohydroxamic acid and pharmaceutical composition containing it
IL90191A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
AU625163B2 (en) Dihydrocaffeic acid derivatives and pharmaceutical preparations containing same

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231